Third Harmonic Bio
THRD
THRD was delisted on the 30th of July, 2025.
84 hedge funds and large institutions have $597M invested in Third Harmonic Bio in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 6 closing their positions.
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
100% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 18
14% more capital invested
Capital invested by funds: $523M → $597M (+$73.4M)
11% more funds holding
Funds holding: 76 → 84 (+8)
8.85% more ownership
Funds ownership: 98.28% → 107.12% (+8.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$29.9M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$18.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.96M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.77M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$1.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.32M |
| 2 |
CC
Commodore Capital
New York
|
-$2.29M |
| 3 |
SCM
Sio Capital Management
New York
|
-$2.12M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$916K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$899K |
THRD Hedge Fund Activity: Q3 2024 in Review
84 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q3 2024, worth a combined $597M — up 14% from $523M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new THRD positions and 6 closed out — a net gain of 8 holders — while 36 added to existing stakes and 18 trimmed.
The largest buyer was TCG Crossover Management, opening a new position worth an estimated $29.9M. The largest seller was RA Capital Management, cutting an estimated $9.32M.
- 84 institutional investors held Third Harmonic Bio (THRD) as of Q3 2024, up from 76 in Q2 2024.
- Funds reported $597M of Third Harmonic Bio stock for Q3 2024, up 14% quarter-over-quarter.
- 14 funds opened new Third Harmonic Bio positions in Q3 2024 and 6 closed out, a net change of +8 holders.
- The largest Third Harmonic Bio buyer in Q3 2024 was TCG Crossover Management, an estimated $29.9M added.
- The largest Third Harmonic Bio seller in Q3 2024 was RA Capital Management, an estimated $9.32M sold.
Based on aggregated 13F filings for Q3 2024.